In aerobic respiration, the tricarboxylic acid (TCA) cycle is pivotal to the complete oxidation of carbohydrates, proteins and lipids to carbon dioxide and water. Plasmodium falciparum, the causative agent of human malaria, lacks a conventional TCA cycle and depends exclusively on glycolysis for ATP production. However, all the constituent enzymes of the TCA cycle are annotated in the genome of P. falciparum implicating that the pathway might be having important, yet unidentified biosynthetic function(s 
INTRODUCTION
Plasmodium falciparum is a parasitic protozoan, which causes the most severe form of malaria in humans. Due to the emergence of wide spread drug resistance in the parasite to most of the first line antimalarials, development of new drugs that target the parasite metabolism is needed. Over several years, malarial parasites have been studied to understand various novel biochemical features, which not only give opportunities for chemotherapeutic interventions, but also stimulate broader scientific interests.
During the intraerythrocytic stages of P. falciparum, the tricarboxylic acid (TCA) cycle does not seem to function like a conventional TCA cycle for the following reasons: (a) Bulk of the glucose is metabolized to lactate by anaerobic glycolysis, which is then secreted by the parasite as a metabolic waste (1) (2) . As a result, unlike aerobic cells, in P. falciparum, there is minimal carbon flow from the cytoplasm to the mitochondrial TCA cycle, (b) the multi-enzyme complex pyruvate dehydrogenase, which channels pyruvate into TCA cycle through acetyl-CoA has been found to localize on the apicoplast membrane in P. falciparum (3) , which is unlike mammalian cells, where the enzyme is present on the inner mitochondrial membrane (4), (c) the enzyme isocitrate dehydrogenase generates NADPH rather than NADH (5) , thereby implicating that its main role is probably to act as a redox sensor rather than donating reducing equivalents to the electron transport chain.
In addition to this, P. falciparum synthesizes ATP mainly by substrate level phosphorylation through glycolysis and not through oxidative phosphorylation (6) , suggesting that the primary function of TCA cycle in generating reducing equivalents for the electron transport chain might be dispensable for the parasite. However, genes for all the enzymes of the TCA cycle are present and are expressed in P. falciparum (7) (8) during the intraerythrocytic stages thereby implicating that the pathway probably has important, yet unidentified biosynthetic functions.
Unlike its human host, P. falciparum lacks the de novo purine biosynthetic pathway and is hence, completely dependent on the purine salvage pathway to meet its purine nucleotide requirements (9) . In the purine salvage pathway, hypoxanthine salvaged from the host is phosphoribosylated to IMP, which then branches out to form AMP and GMP (Fig. 1) . IMP is converted to AMP in two steps catalyzed by two distinct enzymes: (a) adenylosuccinate synthetase (ADSS), which adds a molecule of aspartate to the 6-oxo position of IMP with a concomitant hydrolysis of GTP to GDP to produce succinyl-AMP (10) and (b) cleavage of succinyl-AMP to AMP and fumarate by adenylosuccinate lyase (ASL) (11) . Excess AMP is deaminated back to IMP by AMP deaminase. This cyclic conversion of IMP to AMP constitutes the purine nucleotide cycle ( Fig. 1) , which has been shown to play an important role under conditions (such as in the muscle tissue) requiring excess ATP (12) . P. falciparum genome contains a homolog of AMP deaminase suggesting the presence of the purine nucleotide cycle in the parasite. Apart from AMP, the other end product of this pathway is fumarate, which in most aerobic cells, feeds into the tricarboxylic acid (TCA) cycle (13) . However, in view of a dysfunctional TCA cycle in P. falciparum, the metabolic fate of fumarate is not known.
Our studies with metabolic tracers implicate that fumarate generated from the purine salvage pathway is incorporated into nucleic acids and proteins and not secreted out by the parasite. Fumarate gets converted to malate and then subsequently to aspartate through a metabolic pathway that involves fumarate hydratase, malate quinone oxidoreductase and aspartate aminotransferase. This report shows functionality to a portion of the TCA cycle and also highlights a possible metabolic cross talk between purine salvage and the electron transport chain in P. falciparum.
EXPERIMENTAL PROCEDURES Reagents
All 
P. falciparum culture maintenance
The 3D7 strain of P. falciparum was cultured in vitro as described previously (14) . 14 C]-fumarate (500 μM) were added to erythrocytes, parasitized erythrocytes (2 % hematocrit and 6-8 % parasitemia, 200 µl) or saponin released free parasites (total protein: 2-3 mg ml -1 ). While erythrocytes and parasitized erythrocytes were incubated for 24 or 48 h, saponin released free parasites were incubated for 8 h at 37 ºC in a 96 well flat-bottomed plate placed in a candle jar. Parasites were in the trophozoite stage before labeling. After incubation, the spent medium of each cell type was collected and was treated with 10 % trichloroacetic acid (TCA) for 15 min. on ice followed by boiling for 10 min. The protein precipitate was removed by centrifugation for 30 min. at 4 ºC. The supernatant was collected, lyophilized and reconstituted in 10-20 μl of distilled water. 2-3 μl of the concentrated media was spotted on a 10 x 5 cm TLC silica gel 60 F 254 plate (Merck, Germany) and air dried. A mobile phase consisting of n-butanol, acetic acid and water in the ratio of 4: 1: 1 was used to run the TLC following which the TLC plate was dried and developed using a Fuji FLA 5000 phosphorimager.
For nucleic acid incorporation, the contents of each well were harvested onto glass fiber filters using a Combi-12 automated cell harvester (Molecular Devices, Sunnyvale, CA), washed extensively with distilled water and dried. The incorporated radioactivity was measured as disintegrations per minute using a Wallac 1409 (Wallac Oy, Turku, Finland) liquid scintillation counter.
To check the incorporation of radioactivity in proteins, the parasite culture was treated with 0.15 % saponin solution for 2-3 min. to release the parasites from the erythrocytes. The parasite pellet was washed 5-6 times in PBS, resuspended in 1X SDSgel loading buffer, boiled for 10 minutes and subjected to 10 % SDS-PAGE. Details of cloning, expression and purification of Pf MDH and PfAAT are given in supplementary section. PfAAT activity measurements were carried out as described by Winter and Dekker (17) with minor modifications.
RT-PCR
Total RNA from parasites was extracted using Trizol reagent (Sigma Chemical Co., St. Louis, USA), treated with DNase I (New England Biolabs, MA, USA) and extracted with phenol and chloroform. cDNA synthesis was carried out using MMLV reverse transcriptase (Amersham, UK) according to manufacturer's instructions. DNase treated total RNA was used as a control in PCR reactions to rule out DNA contamination. Specific primers were used in separate PCR reactions for checking the expression of the genes. Primer sequences for RT-PCR are provided in supplementary information.
Generation of polyclonal antibodies against
P. falciparum malate dehydrogenase (MDH) and aspartate aminotransferase (AAT).
The purified PfMDH (100 µg) was injected subcutaneously into a healthy New Zealand White rabbit after emulsification in complete Freund's adjuvant followed by two boosters in incomplete Freund's adjuvant each separated by 14 days. Purified PfAAT (100 µg) was injected into mice (BALB/c) and subsequent injections were same as in the case of PfMDH. Antiserum was collected from the animals at the end of 14 days after second booster and was stored at 4 ºC to allow complete coagulation of blood. The serum was separated by centrifugation. The supernatant was stored in aliquots in sterile tubes at -20 ºC till further use.
Digitonin permeabilization of free parasites and Western blotting
Free parasites were treated with increasing concentrations of digitonin as described earlier (18) with minor modifications. Total protein lysates were separated by SDS-PAGE (12 %) and blotted onto a PVDF membrane using a Hoefer wet transfer apparatus (Hoefer®, Inc., MA, USA). Immunodetections were performed using the primary antibodies, mouse anti-PfAAT (1:2000), rabbit anti-PfMDH (1:2000), and rabbit anti-PfHSP60 (1:1000). As secondary antibodies, anti-mouse or anti-rabbit IgG conjugated to horseraddish peroxidase (Sigma Chemical Co., St. Louis, USA) were used. Western blots were developed using Pierce Super Signal West Pico Chemiluminiscent kit as described by the manufacturer.
Indirect immunofluorescence
Indirect immunofluorescence was done as described earlier (19) with minor modifications and is described in the supplementary section.
RESULTS

Fumarate is incorporated into nucleic acid and protein fractions of P. falciparum
In the purine salvage pathway, the overall reaction of adenylosuccinate synthetase and adenylosuccinate lyase involves the transfer of an α amino group from aspartate to the 6-oxo group of IMP to generate AMP, with the rest of the carbon skeleton of aspartate being released as fumarate. To check whether P. falciparum secretes fumarate as a metabolic waste, PRBCs were incubated with 1 µCi of U-[ 14 C]-aspartate for 24 h and spent medium was analyzed. RBCs were also incubated with the label as a control. U-[
14 C] aspartate is expected to produce U-[
14 C] fumarate as a consequence of the purine salvage pathway ( Fig. 2A) and, if the latter is a metabolic waste, it should be secreted out by PRBCs into the medium. Upon examination of the spent medium of RBCs and PRBCs by TLC, no radioactive spot corresponding to the mobility of [ 14 C]-fumarate could be observed (Fig. 2B) . To increase the sensitivity of the assay, the spent medium was concentrated before spotting and the TLC plate was exposed for a longer time. Still, a spot corresponding to the mobility of fumarate continued to be absent (data not shown).
The failure to detect fumarate in the spent medium could also be because of limited uptake and metabolism of aspartate by PRBCs. However, PRBCs incubated with [ 14 C]-U-aspartate showed a significant amount of radioactivity in the nucleic acid and protein fractions (Fig. S1) indicating that U-[
14 C]-aspartate is taken up and metabolized by the PRBCs. Saponin released erythrocyte free parasites also showed a dose dependant incorporation of [ 14 C]-U-aspartate in to the nucleic acids (Fig. S1 ). Aspartate incorporation in the nucleic acids could be explained by the fact that P. falciparum synthesizes pyrimidines by the de novo pathway in which, the carbon skeleton of aspartate forms the backbone of the pyrimidine ring. These results imply that fumarate generated by the purine salvage pathway in P. falciparum is not secreted out in the medium and hence, is not a metabolic waste.
Therefore (Fig. 3A) . PRBCs showed significant incorporation of radioactivity with counts in control erythrocytes being very low (Fig. 3B) . Interestingly, radioactivity was also seen associated with the protein fraction of PRBCs with all the protein bands obtained from the cell lysate being radiolabeled (Fig.  3C) showed maximum radioactive incorporation in UMP, followed by CMP with counts in GMP and AMP fractions being insignificant (Fig. 4D) . These results indicate that fumarate incorporation into nucleic acids is not through the ribose moiety (as in that case, both purines and pyrimidines should be labeled) but specifically through the pyrimidine backbone. We therefore predict that fumarate is converted to aspartate and then incorporated into proteins and nucleic acids of P. falciparum.
Intermediates in fumarate metabolism
Examination of the KEGG metabolic pathway database (20) highlights two possible routes for the formation of aspartate from fumarate. The first includes the metabolic intermediates, malate and oxaloacetate while the second is a direct conversion of fumarate to aspartate catalyzed by the enzyme aspartase (Fig. 5A) (Fig. S2) . No difference in % incorporation was observed across untreated and treated parasite cultures ruling out the toxicity of these intermediates to P. falciparum growth and thus, supporting the existence of a common pathway for the metabolism of 14 C-fumarate, malate and oxaloacetate.
To further confirm the nature of the intermediary metabolites, free parasites were incubated with 10 mM of 13 C-2,3-fumarate for 4 h in 1 X PBS and then processed for 13 C-NMR analysis. 13 C-proton decoupled NMR of the parasites showed 13 Cenrichment in fumarate (chemical shift of C-2, C-3 carbons in fumarate is at 136 ppm). The other dominant peaks were found at 70 ppm and 42 ppm, which correspond to the C-2 and C-3 of malate respectively. In addition to these, 13 C enrichment was also found in aspartate (C-2, δ :52 ppm and C-3, δ :36 ppm) and pyruvate (C-2, δ: 205 ppm and C-3, δ: 26 ppm) (Fig. 5C) . Integration of the peak areas of fumarate, malate, aspartate pyruvate and lactate in the 13 C-NMR spectrum shows the following relative enrichments: Fumarate: 55.9 ± 16 %, Malate: 39.5 ± 17%, Aspartate: 2.89 ± 0.62 %, Pyruvate: 2 ± 1.2 % and lactate: 1.2 ± 0.5 %. On the other hand, RBCs incubated with 13 C-2,3-fumarate showed enrichment in fumarate, malate and lactate (Fig. 5B) .
Free parasite culture incubated with 14 C-fumarate was used to compare the radioactive counts metabolized and retained within the parasite to that secreted. The spent medium had 48 ± 7% of the input counts while 28 ± 5% of the counts were associated with the cellular fraction. Upon separation of the spent medium on TLC, all the counts were found to be mainly in the lower spot corresponding to malate. It should be noted here that the spot corresponding to the mobility of malate might as well include other polar metabolites such as aspartate, pyruvate and lactate. Taken together with the NMR data this spot should largely contain malate.
Enzymes involved in fumarate to aspartate conversion pathway
Enzymes catalyzing the conversion of fumarate to aspartate are fumarate hydratase (FH), malate dehydrogenase (MDH) or malate quinone oxidoreductase (MQO) and aspartate aminotransferase (AAT). P. falciparum genome contains homologues of all these enzymes. Earlier, it was shown that malate dehydrogenase is cytosolic (21) (22), but the subcellular localization of other enzymes is unknown. RT-PCR analysis shows the expression of FH, MQO and AAT (Fig. 6A) .
Fumarate hydratase is an enzyme that catalyzes the reversible conversion of fumarate to malate. Free parasites were treated with increasing concentrations of digitonin to prepare distinct cytosolic and organellar protein fractions. Digitonin is a non-ionic detergent used to solubilize cellular and organellar membranes. At lower concentrations of digitonin, cell membrane is permeabilized and cytosolic proteins are released whereas at subsequent higher concentrations, the organellar and nuclear membranes are solubilized and organellar extracts are obtained. As PfMDH is cytosolic, it was used as a cytosolic marker in experiments reported here. Digitonin concentration required to fully release cytoplasmic proteins from free parasites was obtained by using antisera against the cytoplasmic marker protein, malate dehydrogenase. On the other hand, antisera against Pf Heat Shock Protein 60 (Pf HSP 60) (a kind gift from Prof. G. Padmanabhan, Indian Institute of Science) were used as mitochondrial marker. From the Western blot analysis, these values were obtained as 0.17 mM and 3.5 mM, respectively ( Fig. 6B  and 6C ).
The digitonin extracts were probed for P. falciparum fumarate hydratase through its enzymatic activity for formation of 14 C-malate from 14 C-fumarate. Porcine heart fumarase (Sigma Chemical Co., St. Louis, USA) was used as a positive control. Pf fumarate hydratase (PfFH) activity was found to be more in the cell extracts obtained by permeabilization with higher digitonin concentrations of 3.5 and 7.0 mM (Fig. 6D) . This indicates that PfFH is not cytosolic, but probably mitochondrial. In support of this, PfFH shows a very high probability (0.89) of getting targeted to mitochondria as predicted by MitoProt II 1.0a4 program (23) .
Antisera raised against recombinant P. falciparum aspartate aminotransferase (Pf AAT) specifically recognized a protein of 50kDa, the expected molecular weight of the enzyme. Earlier studies on cloning, expression and substrate specificity of recombinant PfAAT had revealed that the enzyme catalyzes the transamination of α-ketomethylthiobutyrate to generate methionine (24) . The authors had speculated that this enzyme has an important role in methionine recycling. However, the subcellular localization of this enzyme was not known. Western blotting analysis on digitonin extracts showed that PfAAT is present in the cytosolic extracts (Fig. 6E) . This was further confirmed by confocal microscopy (Fig. 6F) where no co localization of PfAAT (red) was found with the mitochondrial marker, PfHSP60 (green). The K m and k cat values for the conversion of α-ketoglutarate to glutamate by PfAAT were reported by Berger et al., (24) . The K m for aspartate was found out to be 6 mM when α-ketoglutarate was used at a concentration of 10 mM. However, it was not known whether the enzyme could catalyze the reverse reaction of oxaloacetate to aspartate. Hence, recombinant purified PfAAT was characterized for its ability to catalyze the conversion of oxaloacetate to aspartate. The enzyme was found to be active in the direction of formation of aspartate with a K m value for glutamate to be 8 ± 1 mM and oxaloacetate to be 5 ± 0.5 mM. Hence, the enzyme has got similar propensity to catalyze the reaction in both the forward and reverse reactions.
Atovaquone inhibits the conversion of fumarate to aspartate
The conversion of malate to oxaloacetate can be through malate dehydrogenase (MDH) or malate quinone oxidoreductase (MQO). The latter generates reduced coenzyme Q (CoQH 2 ), from coenzyme Q (CoQ) along with the oxidation of malate to oxaloacetate. CoQH 2 is then oxidized directly by complex III and the reducing equivalents are transferred to cytochrome C. Atovaquone is a specific and a potent inhibitor of the enzymatic activity of P. falciparum complex III (25) and thus, treatment of P. falciparum parasites should lead to a depletion of CoQ. We examined the effect of this depletion of CoQ on the conversion of fumarate to aspartate. While 13 C-enrichment in malate was unaffected in atovaquone treated parasites, which was expected as fumarate hydratase is unaltered by atovaquone, these parasites did not show 13 C-enrichment in aspartate (Fig. 7) . This indicates that malate to oxaloacetate conversion is chiefly mediated through the putative P. falciparum malate quinone oxidoreductase and also establishes a metabolic link between the purine salvage pathway and the electron transport chain.
DISCUSSION
It was shown that P. falciparum does not incorporate 14 C-glucose (1) or 13 Cglucose (26) significantly into the TCA cycle intermediates. However, metabolite analysis of P. falciparum extracts in the intraerythrocytic stages by NMR (27) and ESI-MS/MS (28) indicated the presence of fumarate and its intracellular concentration was estimated to be about 0.2 mM (27) . The most convincing evidence for the presence of intracellular pool of fumarate comes from the study by Painter et al., (29) . The study involved generation of transgenic P. falciparum parasites carrying Saccharomyces cerevisiae dihydroorotate dehydrogenase (ScDHODH) along with the endogenous PfDHODH. Both the enzymes oxidize dihydroorotate to orotate, but unlike PfDHODH, which transfers the reducing equivalents to ubiquinone (CoQ), ScDHODH uses fumarate as the electron acceptor. The other difference between the two enzymes is their subcellular localization. While PfDHODH is localized to the mitochondrial inner membrane (30), ScDHODH-GFP fusion protein is localized to the cytoplasm (29) . Although the authors have not speculated on the source of fumarate, these results implicate that there is sufficient intracellular pool of cytosolic fumarate to sustain the activity of ScDHODH in the transgenic parasites. The source of this cytosolic fumarate must be the purine salvage pathway, which generates a molecule of fumarate along with the synthesis of a molecule of AMP. In the absence of a functional TCA cycle during the intraerythrocytic stages of P. falciparum, the cytosolic fumarate generated from the purine salvage pathway as shown by radio-TLC is not secreted out and therefore, must be metabolized in the cell.
Our results show that fumarate gets incorporated into proteins and nucleic acids and also labels specifically pyrimidines and not the purines. Previously, P. falciparum (31) , P. knowlesi (32) and P. lophurae (33) have been shown to fix radiolabelled CO 2 into amino acids glutamate, aspartate and alanine and it was proposed to be mediated through the concerted enzymatic action of carboxykinases followed by transaminases. However, we rule out such a pathway to explain our results because we have used 2,3-[ Earlier, Fry and Beesley observed that isolated mitochondria of P. yoelli and P. falciparum could reduce cytochrome c in the presence of NADH, alpha-glycerophosphate and succinate (34), which are substrates for NADH dehydrogenase, alpha-glycerophosphate dehydrogenase and succinate dehydrogenase, respectively. The authors found that fumarate inhibited the reduction of cytochrome c implicating the presence of a fumarate reductase activity in P. falciparum. On the other hand, Uyemura et al., (35) found that fumarate increased the mitochondrial membrane potential in isolated P. yoelli parasites. These two results are completely contradictory with respect to the direction of fumarate metabolism. Fry and Beesley's results implicate a fumarate reductase activity in which, fumarate is reduced to succinate with concomitant oxidation of reduced ubiquinone (CoQH 2 ) to ubiquinone (CoQ) whereas results obtained by Uyemura et al. (35) implicate that fumarate (by the action of fumarate hydratase) is converted to malate, which is a substrate for malate quinone oxidoreductase and hence, would be oxidized to oxaloacetate. The oxidation of malate to oxaloacetate generates reduced ubiquinone (CoQH 2 ), which then feeds the electron transport chain at complex III. Our 13 C-NMR experiments show peaks corresponding to malate, aspartate and pyruvate. This excludes a direct route of conversion of fumarate to aspartate, which is supported by the absence of a homolog of aspartate ammonia lyase in P. falciparum genome (7). The observation of 13 Cpyruvate can be explained by the action of phosphoenolpyruvate carboxykinase (PEPCK) on oxaloacetate to generate phophoenol pyruvate (PEP), which then forms pyruvate by the action of pyruvate kinase (PK) (Fig. 8) . Both PEPCK and PK have been shown to be expressed in the intraerythrocytic stages of P. falciparum (8) . We did not see any 13 C enrichment for succinate in the 13 C NMR spectrum of free parasites incubated with 2,3-13 C-fumarate indicating the absence of a fumarate reductase activity and also suggesting that succinate dehydrogenase is not bidirectional under the conditions of this study. This is unlike Trypanosoma cruzi, a pathogenic protozoan responsible for the Chagas disease. It was found that T. cruzi intact cells upon incubation with 1-[
13 C]-glucose showed 13 C enrichment at the C-2 position of succinate (36) . A functional fumarate reductase was identified and knockdown of this enzyme led to the accumulation of fumarate in the spent medium of T. cruzi cells (37) .
Pf fumarate hydratase (FH), which catalyzes the first step of fumarate to malate conversion seems to be localized in the mitochondria, given the increased activity of PfFH in mitochondrial extracts. However, as the purine salvage pathway in P. falciparum is cytosolic, the generated fumarate must enter the mitochondria. Several mitochondrial carrier proteins have been found to be present in P. falciparum that could mediate the reversible transport of metabolites into the mitochondria (38) . One of them is the malate-oxoglutarate translocator, which transports malate into mitochondria in exchange for oxoglutarate (38) . RT-PCR analysis shows that this translocator is expressed in the parasite (Fig.  6A) . However, this transporter is not characterized for its substrate specificity and it is possible that this translocator might be involved in the transport of fumarate from the cytosol to the mitochondria.
P. falciparum obtains most of its amino acids from host hemoglobin degradation (39) and thus, the parasite may not completely rely on this metabolic pathway for its aspartate requirements. However, the conversion of fumarate to aspartate as shown in Fig. 8 might serve a key role in replenishing the electron transport chain and thereby, contributing to the maintenance of the mitochondrial membrane potential through the conversion of malate to oxaloacetate. The mitochondrial membrane potential has been speculated to play an important role in the transport of proteins, solutes, ions across the mitochondria. In addition to this, the conversion of fumarate to aspartate might be a possible regulatory mechanism by which purine salvage pathway modulates the de novo pyrimidine biosynthetic pathway in P. falciparum. To what extent it does, is yet to be confirmed. Further, metabolism of fumarate ensures a mechanism to prevent its feedback inhibition of purine salvage pathway.
Our 13 C-NMR observations seem to indicate that bulk of fumarate is converted to malate with a small proportion further converted to aspartate. However, this relative enrichment of 13 C represents a steady state condition. Aspartate feeds into synthesized proteins and its carbon skeleton through pyrimidine nucleotides feeds into nucleic acids and with both these processes being highly active in the trophozoite stage of the parasite, the steady state concentration of free 13 C-enriched aspartate would be expected to be low. Also, it should be noted that apart from labeling proteins and nucleic acids through pyrimidines, 13 C aspartate would also be utilized for AMP synthesis from IMP. This would regenerate 13 Cfumarate that would add to the pool of unutilized 13 C-fumarate and renter the pathway.
Further, comparison of the relative levels of secreted malate with that metabolized and retained intracellularly using 14 C fumarate (500 µM) indicated a partitioning of 48 % and 28 %, respectively. A recent report by Olszewski et al., highlighted that glutamine feeds the TCA cycle intermediates through 2-oxoglutarate in P. falciparum (40) . The authors have shown that malate is secreted out and also fumarate, but the latter to a much lesser extent. Indeed, our observations agree with the findings of Olszewski et al (40) . However, a moderate flux of malate to oxaloacetate does seem to be operating in the parasite, which might be of physiological relevance. In a recent report by Storm and Muller (41) , it was found that phosphoenolpyruvate carboxylase (an enzyme that converts phosphoenolpyruvate to oxaloacetate) null parasites could be generated only in the presence of excess malate. Further, growth of these parasites could be recovered with malate or aspartate. These observations show that malate to oxaloacetate conversion does seem to take place physiologically and oxaloacetate is at a critical node in parasite metabolism. Conversion of malate to oxaloacetate cannot occur through PfMDH as this enzyme has been shown to catalyze only the reduction reaction. We also examined different conditions that are known to activate MDH from other organisms to catalyze malate to oxaloacetate conversion namely presence of citrate and aspartate aminotransferase. But these failed to alter the direction of conversion by recombinant PfMDH (data not shown). MQO is a CoQ dependent dehydrogenase and the absence of 13 C enrichment in aspartate in parasites incubated with atovaquone and 2,3-13 Cfumarate indicates that this enzyme from the parasite catalyses the oxidation of malate to oxaloacetate. Indeed PfMQO exhibits high homology to MQO from Helicobacter pylori (42) , which has been shown to convert malate to oxaloacetate and not the reverse. A genetic approach that obliterates fumarate production would throw more light on the importance of this pathway.
Overall, our findings suggest roles for the enzymes fumarate hydratase, malate quinone oxidoreductase and aspartate aminotransferase. Fumarate hydratase in P. falciparum belongs to the Type I class, which is unlike Type II fumarate hydratase found in the human host (38) . A counterpart of malate quinone oxidoreductase is absent in the human host. A recent study that appeared while the manuscript was under revision reports that PfAAT inhibition is lethal to the parasite (43) . These enzymes could therefore, be targeted for development of antimalarial chemotherapeutics. Our findings also underscore the key role of mitochondrial dicarboxylate transporters in P. falciparum. Fumarate generated in the cytosol has to be translocated into the mitochondria and our results suggest the need for transport of oxaloacetate from mitochondria to cytosol. Animal mitochondria under normal physiological conditions do not transport oxaloacetate significantly and only a minor amount is transported through the dicarboxylate or oxoglutarate-malate translocator. On the other hand, plant mitochondria transport oxaloacetate at rapid rates across the inner mitochondrial membrane (44) . A BLAST search highlighted several translocators with unknown functions in P. falciparum (38) that require further characterization with regard to their cellular localization and specificity for different dicarboxylic acids. Cytosolic fumarate generated from the purine salvage pathway gets metabolized to malate by mitochondrial fumarate hydratase, which then gets converted to oxaloacetate by malate quinone oxidoreductase. In the latter step, CoQ is reduced to CoQH 2 , which is subsequently oxidized back to CoQ by Complex III. Finally, oxaloacetate is converted to aspartate by a cytosolic aspartate aminotransferase. 
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